These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21189224)

  • 1. Systems approaches to molecular cancer diagnostics.
    Ma S; Funk CC; Price ND
    Discov Med; 2010 Dec; 10(55):531-42. PubMed ID: 21189224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
    Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
    Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathology - the value of an integrative approach.
    Salto-Tellez M; James JA; Hamilton PW
    Mol Oncol; 2014 Oct; 8(7):1163-8. PubMed ID: 25160635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics.
    Singer F; Irmisch A; Toussaint NC; Grob L; Singer J; Thurnherr T; Beerenwinkel N; Levesque MP; Dummer R; Quagliata L; Rothschild SI; Wicki A; Beisel C; Stekhoven DJ
    BMC Med Inform Decis Mak; 2018 Oct; 18(1):89. PubMed ID: 30373609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations for standardizing predictive molecular pathology for cancer prognosis.
    Fiorentino M; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
    Expert Rev Mol Diagn; 2017 Jan; 17(1):47-55. PubMed ID: 27897454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
    Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lab-on-a-chip systems in the point-of-care diagnostics].
    Szabó B; Borbíró A; Fürjes P
    Orv Hetil; 2015 Dec; 156(52):2096-102. PubMed ID: 26686745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology.
    Mittempergher L; Delahaye LJMJ; Witteveen AT; Spangler JB; Hassenmahomed F; Mee S; Mahmoudi S; Chen J; Bao S; Snel MHJ; Leidelmeijer S; Besseling N; Bergstrom Lucas A; Pabón-Peña C; Linn SC; Dreezen C; Wehkamp D; Chan BY; Bernards R; van 't Veer LJ; Glas AM
    J Mol Diagn; 2019 Sep; 21(5):808-823. PubMed ID: 31173928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets.
    Sahm F; Schrimpf D; Jones DT; Meyer J; Kratz A; Reuss D; Capper D; Koelsche C; Korshunov A; Wiestler B; Buchhalter I; Milde T; Selt F; Sturm D; Kool M; Hummel M; Bewerunge-Hudler M; Mawrin C; Schüller U; Jungk C; Wick A; Witt O; Platten M; Herold-Mende C; Unterberg A; Pfister SM; Wick W; von Deimling A
    Acta Neuropathol; 2016 Jun; 131(6):903-10. PubMed ID: 26671409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Next Generation of Molecular Pathology is Here: Validation of Next-Generation Sequencing Technology for Clinical Molecular Testing Across Multiple Different Disciplines.
    Weck KE
    Arch Pathol Lab Med; 2017 Jun; 141(6):749-750. PubMed ID: 28557596
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular pathology in real time.
    Ryška A
    Cancer Metastasis Rev; 2016 Mar; 35(1):129-40. PubMed ID: 26931654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of Liquid Biopsies into Clinical Laboratory Applications via NGS in Cancer Diagnostics.
    Sonmezler O; Boga I; Bisgin A
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry as a Practical Tool in Molecular Pathology.
    Sheffield BS
    Arch Pathol Lab Med; 2016 Aug; 140(8):766-9. PubMed ID: 27472235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.
    Donovan MJ; Cordon-Cardo C
    Mol Diagn Ther; 2017 Apr; 21(2):115-123. PubMed ID: 28000172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding molecular diagnostic technology in oncology through the lens of lung cancer.
    Jonna S; Giaccone G; Subramaniam DS
    Discov Med; 2018 Aug; 26(141):21-29. PubMed ID: 30265852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathology as the driving force for personalized oncology.
    Oktay MH; Hui P
    Expert Rev Mol Diagn; 2012 Nov; 12(8):811-3. PubMed ID: 23249199
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.